COSMIC-313 Trial of Cabozantinib, Nivolumab and Ipilimumab in Frontline Advanced RCC

Video

The doctors review data from the COSMIC-313 trial investigating a frontline triplet therapy for advanced RCC.

CN_RO-360_RCC_Seg09_COSMIC
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected